The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?
C Ernstsen, SL Christensen, RH Rasmussen… - Brain, 2022 - academic.oup.com
Calcitonin gene-related peptide (CGRP)-antagonizing drugs represent a major advance in
migraine treatment. However, up to 50% of patients do not benefit from monoclonal …
migraine treatment. However, up to 50% of patients do not benefit from monoclonal …
The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?
C Ernstsen, SL Christensen, RH Rasmussen… - Brain, 2022 - research.regionh.dk
Calcitonin gene-related peptide (CGRP)-antagonizing drugs represent a major advance in
migraine treatment. However, up to 50% of patients do not benefit from monoclonal …
migraine treatment. However, up to 50% of patients do not benefit from monoclonal …
The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?
C Ernstsen, SL Christensen… - Brain: a Journal of …, 2022 - europepmc.org
Calcitonin gene-related peptide (CGRP)-antagonizing drugs represent a major advance in
migraine treatment. However, up to 50% of patients do not benefit from monoclonal …
migraine treatment. However, up to 50% of patients do not benefit from monoclonal …
The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?
C Ernstsen, SL Christensen, RH Rasmussen… - Brain, 2022 - academic.oup.com
Calcitonin gene-related peptide (CGRP)-antagonizing drugs represent a major advance in
migraine treatment. However, up to 50% of patients do not benefit from monoclonal …
migraine treatment. However, up to 50% of patients do not benefit from monoclonal …